Newborn Screening/Testing Market worth $ 819.6 Million by 2019 - New Research Report by MarketsandMarkets
(PRWEB) September 19, 2014 -- According to a new market research report, "Newborn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019" The global newborn screening market was valued at an estimated $438.9 million in 2013 and is expected to reach $819.6 million by 2019, growing at a CAGR of 11.0% between 2013 and 2019.
Browse 70 market data tables and 16 figures spread through 242 pages and in-depth TOC on "Newborn Screening "
http://www.marketsandmarkets.com/Market-Reports/newborn-screening-market-141676244.html
Early buyers will receive 10% customization on this report.
The report segments this market based on type, technology, product and geography. Among various technologies, the enzyme assays and immunoassays commanded the largest share in 2013, while tandem mass spectrometry is forecasted to be the fastest-growing segment in this market. Factors such as benefits offered by newborn screening programs, legislations and mandates, technological advancements, government support, and expanding panel of newborn diseases are driving the growth of the market. Furthermore, owing to continuous advancements in technology, new and innovative devices are being launched in the market, which is another major factor providing impetus for growth of the market.
Ask PDF Brochure at http://www.marketsandmarkets.com/pdfdownload.asp?id=141676244
The newborn screening market includes newborn disorder screening instruments, hearing screening instruments, pulse oximetry, tandem mass spectrometry, electrophoresis, DNA-based assays, and microarray technologies. The tandem mass spectrometry technology showcases a lucrative growth potential and represents the new revenue pockets. High growth in these markets can be attributed to technological advancements, cost effectiveness, and time-effectives offered by this technology.
Newborn screening market is witnessing significant growth across the globe, due to factors such as benefits offered by newborn screening programs, legislations and mandates, technological advancements, government support, and expanding panel of newborn diseases. Furthermore, various awareness programs and conferences are being organized across the globe, which help in increasing awareness regarding newborn screening. Genetic disorder screening, next-generation sequencing, and digital microfluidics have opened a wide array of opportunities in the newborn screening market. Therefore, companies are focusing on partnerships, collaborations, new product launches, and acquisitions to attain leading positions in the market.
For More Detail Speak to Analyst at http://www.marketsandmarkets.com/speaktoanalyst.asp?id=141676244
The prominent players in the newborn screening market are AB SCIEX LLC (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), Natus Medical Inc. (U.S.), PerkinElmer Inc. (U.S.), Trivitron Healthcare (India), and Waters Corporation (U.S.).
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn at http://www.linkedin.com/company/marketsandmarkets
Mr. Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article